Back to search

Molecule Structure

Scientific Name


Description of the Drug

Setmelanotide is setmelanotide is indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)

Not Available

Company Owner(s)

Rhythm Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Melanocortin receptor 4 SINGLE PROTEIN AGONIST CHEMBL259

Unichem Links

SureChEMBL SCHEMBL21840385
Human Metabolome Database HMDB0304856
DrugBank DB11700
PubChem: Thomson Pharma 17492841
PubChem 11993702
DrugCentral 5416
Guide to Pharmacology 9272